Bromocriptine for peripartum cardiomyopathy

Use of bromocriptine for the treatment of peripartum cardiomyopathy has been there for some time. Prolactin can be cleaved into a toxic 16-kDa prolactin fragment (also called vasoinhibin) mediated by oxidative stress. This prolactin fragment has a role in driving peripartum cardiomyopathy. Hence the role of bromocriptine in the treatment of peripartum cardiomyopathy. Suppression of lactation is a concern while using bromocriptine for peripartum cardiomyopathy.